L-arginine stimulation of glucose-induced insulin secretion through membrane depolarization and independent of nitric oxide

Department of Medical Biochemistry and Genetics, Biochemistry Laboratory A, The Panum Institute, University of Copenhagen, Denmark.

The mechanism of L-arginine stimulation of glucose-induced insulin secretion from mouse pancreatic islets was studied. At 16.7 mmol/l glucose, L-arginine (10 mmol/l) potentiated both phases 1 and 2 of glucose-induced insulin secretion. This potentiation of glucose-induced insulin secretion was mimicked by the membrane depolarizing agents tetraethylammonium (TEA, 20 mmol/l) and K+ (60 mmol/l), which at 16.7 mmol/l glucose obliterated L-arginine (10 mmol/l) modulation of insulin secretion. Thus L-arginine may potentiate glucose-induced insulin secretion by stimulation of membrane depolarization. At 3.3 mmol/l glucose, L-arginine (10 mmol/l) failed to stimulate insulin secretion. In accordance with membrane depolarization by the electrogenic transport of L-arginine, however, L-arginine (10 mmol/l) stimulation of insulin secretion was enabled by the K+ channel inhibitor TEA (20 mmol/l), which potentiates membrane depolarization by L-arginine. Furthermore, L-arginine (10 mmol/l) stimulation of insulin secretion was permitted by forskolin (10 micromol/l) or tetradecanoylphorbol 13-acetate (0.16 micromol/l), which, by activation of protein kinases A and C respectively sensitize the exocytotic machinery to L-arginine-induced Ca2+ influx. Thus glucose may sensitize L-arginine stimulation of insulin secretion by potentiation of membrane depolarization and by activation of protein kinase A or protein kinase C. Finally, L-arginine stimulation of glucose-induced insulin secretion was mimicked by NG-nitro-L-arginine methyl ester (10 mmol/l), which stimulates membrane depolarization but inhibits nitric oxide synthase, suggesting that L-arginine-derived nitric oxide neither inhibits nor stimulates insulin secretion. In conclusion, it is suggested that L-arginine potentiation of glucose-induced insulin secretion occurs independently of nitric oxide, but is mediated by membrane depolarization, which stimulates insulin secretion through protein kinase A- and C-sensitive mechanisms.

This article has been cited by other articles:

				M. Ruiz, P. Singh, S. C. Thomson, K. Munger, R. C. Blantz, and F. B. Gabbai L-arginine-induced glomerular hyperfiltration response: the roles of insulin and ANG II Am J Physiol Regulatory Integrative Comp Physiol, May 1, 2008; 294(5): R1744 - R1751. [Abstract] [Full Text] [PDF]

				O. T. Hardy, H. E. Hohmeier, T. C. Becker, E. Manduchi, N. M. Doliba, R. K. Gupta, P. White, C. J. Stoeckert Jr, F. M. Matschinsky, C. B. Newgard, et al. Functional Genomics of the {beta}-Cell: Short-Chain 3-Hydroxyacyl-Coenzyme A Dehydrogenase Regulates Insulin Secretion Independent of K+ Currents Mol. Endocrinol., March 1, 2007; 21(3): 765 - 773. [Abstract] [Full Text] [PDF]

				N. Ishiyama, M. A. Ravier, and J.-C. Henquin Dual mechanism of the potentiation by glucose of insulin secretion induced by arginine and tolbutamide in mouse islets Am J Physiol Endocrinol Metab, March 1, 2006; 290(3): E540 - E549. [Abstract] [Full Text] [PDF]

				S. Norlin, U. Ahlgren, and H. Edlund Nuclear Factor-{kappa}B Activity in {beta}-Cells Is Required for Glucose-Stimulated Insulin Secretion Diabetes, January 1, 2005; 54(1): 125 - 132. [Abstract] [Full Text] [PDF]

				F. Broglio, C. Gottero, A. Benso, F. Prodam, S. Destefanis, C. Gauna, M. Maccario, R. Deghenghi, A. J. van der Lely, and E. Ghigo Effects of Ghrelin on the Insulin and Glycemic Responses to Glucose, Arginine, or Free Fatty Acids Load in Humans J. Clin. Endocrinol. Metab., September 1, 2003; 88(9): 4268 - 4272. [Abstract] [Full Text] [PDF]

				S. Dallinger, A. Sieder, J. Strametz, M. Bayerle-Eder, M. Wolzt, and L. Schmetterer Vasodilator effects of L-arginine are stereospecific and augmented by insulin in humans Am J Physiol Endocrinol Metab, June 1, 2003; 284(6): E1106 - E1111. [Abstract] [Full Text] [PDF]

				V. Lilla, G. Webb, K. Rickenbach, A. Maturana, D. F. Steiner, P. A. Halban, and J.-C. Irminger Differential Gene Expression in Well-Regulated and Dysregulated Pancreatic {beta}-Cell (MIN6) Sublines Endocrinology, April 1, 2003; 144(4): 1368 - 1379. [Abstract] [Full Text] [PDF]

				A. Schaefer, C. Simon, A. Viola, F. Piquard, B. Geny, and G. Brandenberger L-Arginine: An Ultradian-Regulated Substrate Coupled With Insulin Oscillations in Healthy Volunteers Diabetes Care, January 1, 2003; 26(1): 168 - 171. [Abstract] [Full Text] [PDF]

				G. F. Lewis, A. Carpentier, K. Adeli, and A. Giacca Disordered Fat Storage and Mobilization in the Pathogenesis of Insulin Resistance and Type 2 Diabetes Endocr. Rev., April 1, 2002; 23(2): 201 - 229. [Abstract] [Full Text] [PDF]

				M. Brandle, R. Lehmann, F. E. Maly, C. Schmid, and G. A. Spinas Diminished Insulin Secretory Response to Glucose but Normal Insulin and Glucagon Secretory Responses to Arginine in a Family With Maternally Inherited Diabetes and Deafness Caused by Mitochondrial tRNALEU(UUR) Gene Mutation Diabetes Care, July 1, 2001; 24(7): 1253 - 1258. [Abstract] [Full Text] [PDF]